All posts
-
Conclusions from COVID report land on FDA boss’ desk: Deaths in children investigated
According to a questionable COVID record, 7 fatalities in youngsters are “potentially” or “most likely” associated with COVID-19 vaccinations, confidential …
-
Zealand Pharma seeks partnerships to bring “therapies directly to the brain”
The Danish biotech firm is aiming to create collaborations concentrated on weight-loss therapies that target the mind, according to Zealand Pharma’s primary clinical policema…
-
Novo Nordisk receives Canadian approval for Wegovy against MASH
Ifølge Novo Nordisk emergency room Wegovy den eneste behandlingsmulighed, der emergency room godkendt af Wellness Canada til canadiske borgere med leversygdommen mash.
-
Sonova and Demant gained market share among US veterans in November
On the other hand, Danish listening device producers GN and WS Audiology shed market share in November.
-
Leo Pharma seeks approval for chronic hand eczema treatment for young people in Europe
In this connection, the company has submitted an application to the European Medicines Agency (EMA) to extend the indication for Anzupgo.
-
EC call experts to evaluate CRMA strategic projects
Following round of jobs trying EU calculated condition to be examined in February to May 2026 .
-
Crossmedia and Mile Marker make moves now to grow in their rosters in 2026
Both independents made executive transfer to harness a possible windfall of customers leaving the holding business for far better solution and outcomes …Read More
-
‘There’s tremendous opportunity’: NBA sponsorships lead on European expansion
David Brody, vp, international associate administration group lead on the NBA, explains its pitch to sponsor manufacturers and the way enlargement is not far off…Read More
-
Ad Tech Briefing: How the experts predict digital ad spend will pan out in 2026
Marketers are positioning better focus on cost and efficiency, usually at the cost of openness and control …Read More
-
Why Pinterest wants to buy tvScientific, and what it signals for the CTV ads business
Company growth resources approximate the offer appraisal to be over $300 million, declaring tvScientific’s gross income is about $100 million …Read More
